Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 41 to 50 of 112

TitlePrioritisation programmeDecisionDecision date
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]None selectedNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353None selectedNot selected
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]None selectedNot selected
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]None selectedNot selected
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]None selectedNot selected
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]None selectedNot selected
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]None selectedn/a
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]None selectedNot selected
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]None selectedNot selected
Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All